Litcius/Paper detail

Real-World Experience of Angiotensin Receptor–Neprilysin Inhibition in Reduced Ejection Fraction Heart Failure Patients With Advanced Kidney Disease

Hung‐Yu Chang, Chun‐Cheng Lin, Chieh‐Ju Chao, Yi Lin, Yao-Chang Wang, Chia‐Te Liao, Jin‐Long Huang, Ying‐Hsiang Lee, Chun‐Yao Huang, Li‐Nien Chien, Chien‐Yi Hsu

2022Mayo Clinic Proceedings20 citationsDOI

Topics & Concepts

Ejection fractionMedicineHeart failureInternal medicineCardiologyRenal functionAtrial fibrillationKidney diseasePropensity score matchingAngiotensin receptorAngiotensin IIBlood pressureHeart Failure Treatment and ManagementCardiovascular Function and Risk FactorsBlood Pressure and Hypertension Studies
Real-World Experience of Angiotensin Receptor–Neprilysin Inhibition in Reduced Ejection Fraction Heart Failure Patients With Advanced Kidney Disease | Litcius